560 related articles for article (PubMed ID: 30857216)
1. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives.
Yanai H; Yoshida H
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857216
[TBL] [Abstract][Full Text] [Related]
2. Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo.
Luo N; Wang X; Chung BH; Lee MH; Klein RL; Garvey WT; Fu Y
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E180-6. PubMed ID: 21505149
[TBL] [Abstract][Full Text] [Related]
3. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and lipoprotein metabolism.
Christou GA; Kiortsis DN
Obes Rev; 2013 Dec; 14(12):939-49. PubMed ID: 23957239
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin: A potential therapeutic target for metabolic syndrome.
Ghadge AA; Khaire AA; Kuvalekar AA
Cytokine Growth Factor Rev; 2018 Feb; 39():151-158. PubMed ID: 29395659
[TBL] [Abstract][Full Text] [Related]
7. Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.
Magkos F; Fabbrini E; Patterson BW; Eagon JC; Klein S
Metabolism; 2011 Nov; 60(11):1641-8. PubMed ID: 21632078
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
9. Relationship among adiponectin, insulin resistance and atherosclerosis in non-diabetic hypertensive patients and healthy adults.
Kou H; Deng J; Gao D; Song A; Han Z; Wei J; Jin X; Ma R; Zheng Q
Clin Exp Hypertens; 2018; 40(7):656-663. PubMed ID: 29336612
[TBL] [Abstract][Full Text] [Related]
10. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes.
Ndisang JF; Jadhav A
Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress contributes to abnormal glucose metabolism and insulin sensitivity in two hyperlipidemia models.
Bai J; Zheng S; Jiang D; Han T; Li Y; Zhang Y; Liu W; Cao Y; Hu Y
Int J Clin Exp Pathol; 2015; 8(10):13193-200. PubMed ID: 26722518
[TBL] [Abstract][Full Text] [Related]
12. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
[TBL] [Abstract][Full Text] [Related]
13. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
[TBL] [Abstract][Full Text] [Related]
14. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
[TBL] [Abstract][Full Text] [Related]
15. Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin.
Hoffmann A; Ebert T; Klöting N; Dokas J; Jeromin F; Jessnitzer B; Burkhardt R; Fasshauer M; Kralisch S
Biochim Biophys Acta; 2016 Jan; 1862(1):113-20. PubMed ID: 26521149
[TBL] [Abstract][Full Text] [Related]
16. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
17. A lower proportion of dietary saturated/monounsaturated/polyunsaturated fatty acids reduces the expression of adiponectin in rats fed a high-fat diet.
Yang X; Zhang Y; Lin J; Pen A; Ying C; Cao W; Mao L
Nutr Res; 2012 Apr; 32(4):285-91. PubMed ID: 22575042
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
19. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
[TBL] [Abstract][Full Text] [Related]
20. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
